by Nicholas Brooks, Marketing/Admin Intern; and René Meade, Learning & Development Manager
Only a few decades ago, the idea of altering one’s genes would have been considered science fiction, but today it is an important and promising reality. Gene therapy, the altering of genes in the body to treat or stop illness, Read More→
by Nicholas Brooks, Marketing/Admin Intern; and René Meade, Learning & Development Manager
The Human Immunodeficiency Virus, more commonly known as HIV, continues to be a major global public health issue. According to the WHO, HIV has infected 70 million people and claimed over 35 million lives worldwide since the pandemic began in 1981. Read More→
by Shannon Carroll, Marketing Intern; and René Meade, Learning & Development Manager
The Chinese pharmaceutical market is second in the world, with $145 billion in growth expected by 2022. Through increased spending on research and major reform of the China Food and Drug Administration (CFDA), Read More→
by René Meade, Learning & Development Manager
Diabetes plagues about 422 million people worldwide and is one of the leading causes of death in the world, according to the WHO. Fortunately for diabetes patients, September and October were great months for advances in diabetes care.
Sugarpod foot scanner. Read More→by René Meade, Learning & Development Manager
Drug waste is making the news again with the release of the NPR story Drug Companies Make Eyedrops Too Big, and You Pay for the Waste. The article revives a 1992 American Journal of Ophthalmology study in which researchers determined that eye drops 1/3 – ½ the size of a normal drop are sufficient, Read More→
by René Meade, Learning & Development Manager
Image credit: FreepikIt is October, and in the Americas and Europe, that means pumpkin spice, corn mazes, and Halloween. Halloween is a notoriously dangerous holiday—according to the US National Electronic Injury Surveillance System (NEISS), between 2007 and 2015, Halloween was the holiday with the fifth-highest number of emergency room visits for children. Read More→
by René Meade, Learning & Development Manager
Automation has already taken the healthcare manufacturing sector by storm—thumb through an issue of Pharmaceutical Technology, and you will see solution after solution, all of which claim to cut costs and boost production rate. Read More→
by René Meade, Learning & Development Manager
According to research published in the Journal of Rare Disorders, the mean length of time from symptom onset to accurate diagnosis for patients with rare diseases was 4.8 years. In the meantime, these patients visit an average of 7.3 physicians. Most rare diseases have no cure or treatment, Read More→
by René Meade, Learning & Development Manager
It has been over 20 years since the US Food and Drug Administration began allowing pharmaceutical companies to advertise their products on television. In that time, the controversy surrounding direct-to-consumer (DTC) advertising has created quite a stir. Even so, USA Today reports that spending for pharmaceutical DTC ads has grown 62% in the last 5 years. Read More→
by René Meade, Learning & Development Manager
What if we could use data analytics to discover and treat disease before it even begins? Late last week, Humana and Amgen announced a partnership to accomplish just that: Researchers would using RWE and data from wearable decides to develop algorithms predicting patient risk, Read More→